𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants

✍ Scribed by Gibbons, Deena; Fleming, Paul; Virasami, Alex; Michel, Marie-Laure; Sebire, Neil J; Costeloe, Kate; Carr, Robert; Klein, Nigel; Hayday, Adrian


Book ID
127206587
Publisher
Nature Publishing Group
Year
2014
Tongue
English
Weight
871 KB
Volume
20
Category
Article
ISSN
1078-8956

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


NKG2A is a marker for acquisition of reg
✍ Vitaly Ablamunits; Octavian Henegariu; Paula Preston-Hurlburt; Kevan C. Herold πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 435 KB πŸ‘ 1 views

## Abstract Treatment with anti‐CD3 mAb modulates immune responses that cause type 1 diabetes and other diseases. CD8^+^ Tregs can be induced in vitro and in vivo by mAb. However, 1/3 of patients do not respond to drug therapy and in an equal proportion, anti‐CD3 mAb does not induce Tregs in vitro.